Expert Opinion on the Diagnosis and Treatment of Hematologic Malignancies During Pregnancy
Abstract
The diagnosis and treatment of hematologic malignancies has undergone significant advancements over the past few decades, resulting in enhanced outcomes. For hematologic malignancies diagnosed during pregnancy, this poses new questions. As possibilities continue to expand and the rising global incidence results in an increasing number of diagnoses within the pregnant population, there is a pressing need to gain a deeper understanding of the potential options for pregnant women and the impact on the newborn. As knowledge of the effects of cancer treatment increases, more women are receiving adequate cancer diagnosis and treatment during pregnancy. This paper presents an expert opinion on the use of diagnostic modalities and treatment options, including chemotherapy, radiation therapy, and immunotherapy, for acute leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, myeloproliferative neoplasms, aplastic anemia, and multiple myeloma during pregnancy.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (16)
Daan Dierickx
6University Hospitals Leuven, Leuven, Belgium
Joosje H. Heimovaara
Department of Oncology, KU Leuven, Leuven, Belgium
Mar Bellido
13University Medical Center Groningen and University of Groningen, Groningen, Netherlands
Kristel Van Calsteren
Division of Fetomaternal Medicine, Department of Obstetrics and Gynecology, UZ Leuven, Leuven, Belgium
Elyce Cardonick
Department of Obstetrics and Gynecology, Cooper, University Health Care, Camden, NJ
Alvaro Cabrera Garcia
Hospital Regional de Alta Especialidad de Ixtapaluca (HRAEI) “Reference Clinic for Hemato-oncological Diseases During Pregnancy CREHER” Estado de México, Ixtapaluca, Mexico
Adinda Baten
Department of Radiation Oncology University Hospitals Leuven Leuven Belgium
Andrew M. Evens
Division of Blood Disorders, Rutgers Cancer Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
Andres Ferber
Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
Monica Fumagalli
Elzbieta Lampka
The Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Lena Specht
Copenhagen University Hospital–Rigshospitalet
Vincent Vandecaveye
Department of Radiology, University Hospitals Leuven, Leuven, Belgium
Ivan R. Vogelius
Department of Radiation Oncology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
Markus Alber
Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
Frédéric Amant